Q2 worldwide sales were $241 million, with U.S. sales at $170 million, a 9% increase year-over-year. International sales reached $70 million, with benefits from pump renewals and favorable currency ...
Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters due to innovative product offerings, which continue to gather remarkable enthusiasm. The upcoming scaling of multiple ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of Tandem Source, a diabetes management ...
RBC Capital Markets initiated coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin ...
Hosted on MSN
Why Tandem Diabetes (TNDM) Stock Is Up Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 5% in the morning session after the company announced the publication of a study showing its automated insulin delivery ...
Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters, backed by its impressive lineup of new products. The flourishing diabetes market provides a favorable opportunity for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results